Studies from Second Affiliated Hospital of Hainan Medical University Describe New Findings in Liver Cancer (Anlotinib Combined With Toripalimab as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Prospective, Multicenter, Phase...).

Předmět:	LIVER cancer HEPATOCELLULAR carcinoma HAND-foot syndrome HOSPITALS MEDICAL research
Zdroj:	Clinical Trials Week; 7/4/2023, p1175-1175, 1p
Abstrakt:	According to news originating from Second Affiliated Hospital of Hainan Medical University by NewsRx editors, the research stated, "For patients with unresectable hepatocellular carcinoma (HCC), the first-line therapeutic options are still relatively limited, and treatment outcomes remain poor. Keywords: Cancer; Carcinomas; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Liver Cancer; Oncology; Therapy EN Cancer Carcinomas Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Liver Cancer Oncology Therapy 1175 1175 1 07/03/23 20230704 NES 230704 2023 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Current study results on liver cancer have been published. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu